Article Information
History
- February 11, 2016.
Article Versions
- Version 1 (July 22, 2015 - 11:45).
- Version 2 (August 2, 2015 - 09:45).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Endre Sebestyén1*,
- Babita Singh1*,
- Belén Miñana1,2,
- Amadís Pagès1,
- Francesca Mateo3,
- Miguel Angel Pujana3,
- Juan Valcárcel1,2,4 and
- Eduardo Eyras1,4,5
- 1Universitat Pompeu Fabra, Dr. Aiguader 88, E08003 Barcelona, Spain
- 2Centre for Genomic Regulation, Dr. Aiguader 88, E08003 Barcelona, Spain
- 3Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), E08908 L’Hospitalet del Llobregat, Spain
- 4Catalan Institution for Research and Advanced Studies, Passeig Lluís Companys 23, E08010 Barcelona, Spain
- ↵5Correspondence to: eduardo.eyras@upf.edu
↵* Equal contribution